Publications
- Valproic Acid in the Complex Therapy of Malignant Tumors2010 | Second Faculty of Medicine
- Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells2012 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
- Valproic acid overcomes hypoxia-induced resistance to apoptosis2012 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
- Valproic acid overcomes hypoxia-induced resistance to apoptosis2012 | Second Faculty of Medicine
- Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells2012 | Second Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Second Faculty of Medicine
- Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells2009 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine, Faculty of Mathematics and Physics
- The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells2009 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine
- The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells2008 | Faculty of Physical Education and Sport, First Faculty of Medicine, Second Faculty of Medicine
Loading network view...